GSK may bid for Pfizer consumer unit, stoking dividend fears

LONDON (Reuters) - GlaxoSmithKline will look at acquisition options to bulk up its consumer health business as rivals like Pfizer and Merck KGaA quit the field, its chief executive said on Wednesday.

from Reuters: Health News http://ift.tt/2gC7lED